Every year, millions of people are impacted by respiratory diseases posing substantial health and economic burdens. At Sanofi, we believe more can be done to address the community’s unmet needs. That’s why we’re committed to leveraging our expertise in immunoscience and working to bring forward new paradigm-shifting treatments for respiratory diseases. Learn more:
About us
We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms
- Website
-
http://www.sanofi.com
External link for Sanofi
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Paris, France
- Type
- Public Company
- Specialties
- vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare
Locations
Employees at Sanofi
Updates
-
It’s our role as innovators to remain accountable for the outcomes of our AI tools, as laid out in a growing number of regulatory and legal frameworks. At Sanofi, we believe accountability goes beyond legal compliance as we hold ourselves to the pillars of our Responsible AI strategy across the entirety of our business – from AI developers, to AI end user. Hear from Alessandra Cincotti to learn how we ensure accountability from the design through to use of our AI systems. Learn more about our Responsible AI approach: https://lnkd.in/eQTtp3Ne #ResponsibleAI
-
POV: The Olympic Torch came to our Sanofi R&D Site in Montpellier, France 🔥 Discover the highlights of the day 👇 #Paris2024
-
Just over 2 months to go! We're proud to support Amandine Buchard, part of #TeamSanofi, in her journey to the Olympic Games #Paris2024. 🥇 Cheering her on from the sidelines will be Amandine’s best friend, Julia, whose unwavering support pushed Amandine to achieve her dreams. Watch to learn more about Amandine’s story of resilience 💪 #Paris2024 #IgnitingPotential #TeamSanofi
-
The Olympic Flame just passed through our R&D site in Montpellier, France! 🔥 What an exciting moment for our Sanofians who gathered to celebrate this unique event and cheer on our Sanofi torchbearers. The journey is not over, the relay goes on with lots of key stops coming up. Stay tuned ✨ #IgnitingPotential #Paris2024 Paris 2024 - Comité d'organisation des Jeux Olympiques et Paralympiques de 2024
-
Our 2023 DE&I Report invites you to see, hear, and feel a year of change at Sanofi, as people across the world came together to create a more inclusive, equitable future. Curious how we’ve progressed toward our 2025 ambitions - and what that means for healthcare? Open the report to find out: http://spkl.io/60444NCjA
-
The Olympic Flame brought magic to Marseille 🤩 We were honored to be part of this historic moment, joining thousands of people to kick off the epic Olympic Torch Relay Paris 2024 through France. #Paris2024 #IgnitingPotential
-
Yesterday, 4 Sanofians carried the Olympic Torch in Marseille, France 🇫🇷 Over the next few weeks, the Torch will travel to several Sanofi sites across France, with nearly 300 Sanofians participating as official Torchbearers. Stay tuned! 🔥 Our teams will welcome the Torch at our site in Montpellier on May 13! #IgnitingPotential #Paris2024 #TorchRelay
-
Today, the Olympic Torch has arrived from Greece to begin its relay to France 🇫🇷 Our Sanofians were beyond excited to experience this once in a lifetime event. Tomorrow, 4 Sanofians will be among the first to bear the Olympic Torch. 🔥 Stay tuned! #Paris2024 #IgnitingPotential
-
The Lancet has recently published new data from Galicia, Spain, showing real-world impact on respiratory syncytial virus (#RSV) hospitalizations in infants after the introduction of our #immunization in the 2023-2024 RSV season. Read our press release: http://spkl.io/60414NJgz
Read our press release
sanofi.com